- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
The dosage of Mobocetinib should be determined according to the indications and individual patient conditions. It is mainly used for non-small ...
Finelinone is a selective nonsteroidal mineralocorticoid receptor antagonist, which is mainly used to treat type 2 diabetes related chronic kid...
Mobocetinib is an oral EGFR inhibitor primarily used to treat non-small cell lung cancer carrying EGFR exon 20 insertion mutations. The standar...
Finelinone is a selective nonsteroidal mineralocorticoid receptor antagonist, which is mainly used to treat chronic kidney disease associated w...
Ivosidenib is an IDH1 inhibitor used to treat relapsed/refractory acute myeloid leukemia (AML) patients carrying IDH1 mutations or newly diagno...
Pemigatinib is an FGFR inhibitor used to treat advanced cholangiocarcinoma patients carrying FGFR2 fusion or rearrangement. The treatment cours...
Ivosidenib is an IDH1 inhibitor used to treat relapsed/refractory acute myeloid leukemia (AML) patients carrying IDH1 mutations. The duration o...
Ivosidenib, as a targeted therapy for IDH1 mutant acute myeloid leukemia, usually requires long-term use until disease progression or intolerable...
Ivosidenib, as a targeted therapy for IDH1 mutant acute myeloid leukemia (AML), has clinical effects mainly in inducing differentiation, prolon...
Pemigatinib is a selective FGFR inhibitor mainly used to treat advanced cholangiocarcinoma patients carrying FGFR2 fusion or rearrangement. Its...
